Inherited TP53 Variants and Risk of Prostate Cancer

Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition

(2020) Phuong L. Mai et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

(2020) Thierry Frebourg et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A rare TP53 mutation predominant in Ashkenazi Jews confers risk of multiple cancers

(2020) Jacquelyn Powers et al.   CANCER RESEARCH

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

(2020) Veda N. Giri et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study

(2020) Peter G. Hendrickson et al.   Cancer Medicine

Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017

(2020) David A. Siegel et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

(2020) Cristina Fortuno et al.   HUMAN MUTATION

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines

(2019) Piper Nicolosi et al.   JAMA Oncology

Penetrance of different cancer types in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts

(2019) Seung Jun Shin et al.   CANCER RESEARCH

Revisiting tumor patterns and penetrance in germline TP53 mutation carriers

(2018) Amina Amadou et al.   CURRENT OPINION IN ONCOLOGY

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing

(2018) Huma Q Rana et al.   JNCI-Journal of the National Cancer Institute

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing

(2018) Huma Q Rana et al.   JNCI-Journal of the National Cancer Institute

Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome

(2018) Suzanne P. MacFarland et al.   GASTROENTEROLOGY

Somatic TP53 variants frequently confound germ-line testing results

(2017) Jeffrey N Weitzel et al.   GENETICS IN MEDICINE

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

(2017) Julie Lecarpentier et al.   JOURNAL OF CLINICAL ONCOLOGY

ClinVar: improving access to variant interpretations and supporting evidence

(2017) Melissa J Landrum et al.   NUCLEIC ACIDS RESEARCH

Risks of first and subsequent cancers amongTP53mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort

(2016) Phuong L. Mai et al.   CANCER

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

(2015) Gaëlle Bougeard et al.   JOURNAL OF CLINICAL ONCOLOGY

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

(2015) Donavan T. Cheng et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens

(2013) Colin C. Pritchard et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The genetic epidemiology of prostate cancer and its clinical implications

(2013) Rosalind Eeles et al.   Nature Reviews Urology

Radio-induced malignancies after breast cancer post-operative radiotherapy in patients with Li- Fraumeni syndrome

(2010) Steve Heymann et al.   Radiation Oncology